Skip to main content

Table 1 Relationships between expression of VEGFR-2, PDGFR-β, and C-met and clinicopathological factors

From: Expression and prognostic value of VEGFR-2, PDGFR-β, and c-Met in advanced hepatocellular carcinoma

Parameters

N

VEGFR-2

P

PDGFR-β

P

C-MET

P

High

Low

High

Low

High

Low

N(%)

93

80(86.0)

13

 

18(19.4)

75

 

75(80.6)

18

 

Gender

          

Male

77

69(89.6)

8

 

15(19.5)

62

 

61(79.2)

16

 

Female

16

11(68.8)

5

0.044

3(18.8)

13

0.627

14(87.5)

2

0.355

Age

          

≤50

31

26(83.9)

5

 

6(19.4)

25

 

25(80.6)

6

 

>50

62

54(87.1)

8

0.448

12(19.4)

50

0.602

50(80.6)

12

0.616

HBsAg

          

Positive

79

71(89.9)

8

 

16(20.3)

63

 

63(79.7)

16

 

Negative

14

9(64.3)

5

0.024

2(14.3)

12

0.461

12(85.7)

2

0.461

AFP(IU/ML)

          

≤400

47

39(83.0)

8

 

5(10.6)

42

 

39(83.0)

8

 

>400

46

41(89.1)

5

0.290

13(28.3)

33

0.029

36(78.3)

10

0.377

Tumor number

          

Single

29

26(89.7)

3

 

2(6.9)

27

 

23(79.3)

6

 

>1

64

54(84.4)

10

0.371

16(25.0)

48

0.033

52(81.3)

12

0.516

Tumor size(cm)

          

≤5

16

13(81.3)

3

 

4(25.0)

12

 

13(81.3)

3

 

>5

77

67(87.0)

10

0.394

14(18.2)

63

0.373

62(80.5)

15

0.627

Differentiation

          

High

26

26(100)

0

 

7(26.9)

19

 

21(80.8)

5

 

Middle

45

38(84.4)

7

 

6(13.3)

39

 

35(77.8)

10

 

Low

22

16(72.7)

6

0.023

5(22.7)

17

0.340

19(86.4)

3

0.705

Child-Pugh

          

A

82

70(85.4)

12

 

14(17.1)

68

 

64(78.0)

18

 

B

11

10(90.9)

1

0.523

4(36.4)

7

0.134

11(100)

0

0.080

BCLC

          

B

20

15(75.0)

5

 

2(10.0)

18

 

13(65.0)

7

 

C

73

65(89.0)

8

0.111

16(21.9)

57

0.194

62(84.9)

11

0.051

Hepatic cirrhosis

          

Yes

48

45(93.8)

3

 

5(10.4)

43

 

37(77.1)

11

 

No

45

35(77.8)

10

0.026

13(28.9)

32

0.023

38(84.4)

7

0.263

Ascites

          

Yes

19

17(89.5)

2

 

3(15.8)

16

 

17(89.5)

2

 

No

74

63(85.1)

11

0.476

15(20.3)

59

0.470

58(78.4)

16

0.228

Tumor thrombus

          

Yes

38

33(86.8)

5

 

10(26.3)

28

 

34(89.5)

4

 

No

55

47(85.5)

8

0.551

8(14.5)

47(

0.126

41(74.5)

14

0.061

Extrahepatic metastasis

          

Yes

48

43(89.6)

5

 

8(16.7)

40

 

40(83.3)

8

 

No

45

37(82.2)

8

0.235

10(22.2)

35

0.339

35(77.8)

10

0.339

  1. VEGFR-2, vascular endothelial growth factor receptor-2; PDGFR-β, platelet-derived growth factor receptor-β; C-MET, hepatocyte growth factor receptor; HbsAg, hepatitis B surface antigen; AFP, serum alpha-fetoprotein; BCLC, Barcelona Clinic Liver Cancer stage.